– Reuters Citing Sources
Humacyte Announces Presentations By Ukrainian Surgeons On Use Of The Human Acellular Vessel To Treat Wartime Vascular Trauma At The European Society For Vascular Surgery Annual Meeting
DURHAM, N.C., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues, complex tissue systems, and
